Cisplatin/Durvalumab/Gemcitabine Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cisplatin, gemacitabine and durvalumab that may be used for the treatment of bladder cancer, biliary tract cancer, non-small cell lung cancer (NSCLC), and ampullary adenocarcinoma.

**Synonyms:** - Cisplatin and Gemcitabine (GC) and Durvalumab - Cisplatin-Durvalumab-Gemcitabine - Cisplatin-Durvalumab-Gemcitabine Regimen - Cisplatin/Durvalumab/Gemcitabine - Cisplatin/Gemcitabine Plus Durvalumab Regimen - Cisplatin/Gemcitabine/Durvalumab - Cisplatin/Imfinzi/Gemzar - Durvalumab/Cisplatin/Gemcitabine - Gemcitabine/Cisplatin Plus Durvalumab